Asparaginase (Recombinant) | m-entrepreneurship.com

Product Name :
Asparaginase (Recombinant)

Search keywords :
L-Asparaginase

drugId :
null

Target Vo:
Aspartate-ammonia ligase

Target Vo Short Name :
Aspartate-ammonia ligase

Moa_Name:
Aspartate-ammonia ligase inhibitors

First Approval Country :
EU

First Approval Date Filter:
2016

Origin Company_Name :
Medac

Active Company_Name :
Medac Gesellschaft Fur Klinische Spezialpraeparate Gmbh

Active Indication_Name:
Precursor Cell Lymphoblastic Leukemia-Lymphoma

In Active Indication_Name:
Leukemia, T-Cell

Termination Status :

China Termination Status :
Phase 2 Clinical

Highest Status:
Approved

China Highest Status:
Pending

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Luspatercept Formula
Phospho-STAT1 (Ser727) Rabbit mAb Protocol
RANKL/CD254 Antibody: RANKL/CD254 Antibody is an unconjugated, approximately 35 kDa, rabbit-derived, anti-RANKL/CD254 polyclonal antibody. RANKL/CD254 Antibody can be used for: WB, ELISA, IHC-P, IHC-F, Flow-Cyt, IF expriments in human, mouse, and predicted: rat, dog background without labeling.

Author: Betaine hydrochloride

Related Posts